more information
Search within Results:

Select All    Deselect All
 |   | 
Details
   print
  Record Links
Author (up) Danyuo, Y.; Obayemi, J.D.; Dozie-Nwachukwu, S.; Ani, C.J.; Odusanya, O.S.; Oni, Y.; Anuku, N.; Malatesta, K.; Soboyejo, W.O. file  url
openurl 
  Title Prodigiosin release from an implantable biomedical device: kinetics of localized cancer drug release Type Journal Article
  Year 2014 Publication Materials Science & Engineering. C, Materials for Biological Applications Abbreviated Journal Mater Sci Eng C Mater Biol Appl  
  Volume 42 Issue Pages 734-745  
  Keywords Acrylic Resins/chemistry; Antineoplastic Agents/chemistry/*pharmacokinetics; Chemistry, Pharmaceutical/instrumentation; Diffusion; Drug Delivery Systems/instrumentation; Drug Liberation; Drug Therapy/*instrumentation; Hydrogels/chemistry; Hyperthermia, Induced; Kinetics; Prodigiosin/chemistry/*pharmacokinetics; *Prostheses and Implants; Biomedical device; Breast cancer; Hyperthermia; Localized chemotherapy; Poly(N-Isopropylacrylamide)-based hydrogels; Prodigiosin  
  Abstract This paper presents an implantable encapsulated structure that can deliver localized heating (hyperthermia) and controlled concentrations of prodigiosin (a cancer drug) synthesized by bacteria (Serratia marcesce (subsp. marcescens)). Prototypical Poly-di-methyl-siloxane (PDMS) packages, containing well-controlled micro-channels and drug storage compartments, were fabricated along with a drug-storing polymer produced by free radical polymerization of Poly(N-isopropylacrylamide)(PNIPA) co-monomers of Acrylamide (AM) and Butyl-methacrylate (BMA). The mechanisms of drug diffusion of PNIPA-base gels were elucidated. Scanning Electron Microscopy (SEM) was also used to study the heterogeneous porous structure of the PNIPA-based gels. The release exponents, n, of the gels were found to between 0.5 and 0.7. This is in the range expected for Fickian (n=0.5). Deviation from Fickian diffusion was also observed (n>0.5) diffusion. The gel diffusion coefficients were shown to vary between 2.1x10(-12)m(2)/s and 4.8x10(-6)m(2)/s. The implications of the results are then discussed for the localized treatment of cancer via hyperthermia and the controlled delivery of prodigiosin from encapsulated PNIPA-based devices.  
  Call Number Serial 1605  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations: